Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study).

Saved in:
Bibliographic Details
Title: Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study).
Authors: Kawaguchi Y; Department of Gastroenterology, Asakura Medical Association Hospital, Fukuoka, Japan., Hayashi K; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Shimokawa M; Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan.; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Otsuka T; Department of Internal Medicine, Minato Medical Clinic, Fukuoka, Japan., Nakazawa J; Department of Medical Oncology, Kagoshima City Hospital, Kagoshima, Japan., Shimokawa H; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan., Shinohara Y; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan., Koga F; Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga, Japan., Oza N; Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga, Japan., Oda H; Division of Integrative Medical Oncology, Saiseikai Kumamoto Hospital, Kumamoto, Japan., Takeshita S; Department of Gastroenterology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan., Arima S; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan., Arita S; Department of Chemotherapy, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan., Nishikawa K; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan., Otsu S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan., Taguchi H; Department of Gastroenterology, Imamura General Hospital, Kagoshima, Japan.; Department of Gastroenterology, Kagoshima City Hospital, Kagoshima, Japan., Jikuya K; Department of Gastroenterology, Imamura General Hospital, Kagoshima, Japan., Sakai T; Department of Medical Oncology, NHO Kumamoto Medical Center, Kumamoto, Japan., Ueda Y; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan., Sakae T; Department of Gastroenterology, Saiseikai Sendai Hospital, Kagoshima, Japan., Araki N; Department of Gastroenterology, Saiseikai Sendai Hospital, Kagoshima, Japan.; Department of Gastroenterology, Izumi General Medical Center, Kagoshima, Japan., Sawase H; Department of Internal Medicine, National Hospital Organization Saga Hospital, Saga, Japan., Ide Y; Department of Internal Medicine, National Hospital Organization Saga Hospital, Saga, Japan., Kawahira M; Department of Gastroenterology, Kagoshima Kouseiren Hospital, Kagoshima, Japan., Nio K; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka, Japan., Shirakawa T; Clinical Hematology Oncology Treatment Study Group, 1-14-6 Muromi-gaoka, Nishi-ku, Fukuoka-shi, Fukuoka 819-0030, Japan.; Medical Checkup Center, Eikoh Hospital, 3-8-15 Befu-nishi, Shime-machi, Kasuya-gun, Fukuoka 811-2232, Japan., Mizuta T; Department of Internal Medicine, Fujikawa Hospital, Saga, Japan., Mitsugi K; Department of Medical Oncology, Sasebo Kyosai Hospital, Nagasaki, Japan.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Apr 21; Vol. 18, pp. 17588359261442386. Date of Electronic Publication: 2026 Apr 21 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-8340
DOI:10.1177/17588359261442386